Presbyopia
Phentolamine Phase III Data Shows Success in Quickly Reversing Dilation
Roughly half of test subjects—48.9% in one study and 58% in another—saw a return to baseline pupil size within 90 minutes. Hyperemia and discomfort each occurred in about 11% of patients.
09/20/2024
New Daily Multifocal Lens Accommodates More Presbyopes
The “Clariti 1-day Multifocal 3 Add” uses different optical designs for low, medium and high plus powers and offers a wider sphere range than its predecessor.
07/16/2024
Reading Speed, Gaze Behavior Differs Between Types of Presbyopia Correction
Researchers observed variance in head movements between wearers of single-vision contact lenses, multifocal CLs and progressive addition lenses.
04/10/2024
Unhappy Birthday
More trips around the sun means more chances for your patients to develop the dreaded presbyopia.
12/15/2023
Pilocarpine 1.25% Impacts Night Driving
Study shows clinicians should take this into consideration when prescribing the medication to presbyopes.
12/08/2023
FDA Approves Second Presbyopia Drop
A new low-dose pilocarpine agent can be administered up to twice a day for maximum duration of effect. It is hoped to result in fewer adverse effects than Vuity.
10/18/2023
Alcon Adds Multifocal Option to Total30 Line
The company says the new lens is designed to maintain hydration and comfort throughout a month of wear.
10/10/2023
Experts Attempt to Find Consensus on Presbyopic IOL Use
A panel agreed on many aspects of pre-op and intraoperative decision-making. They disagreed, however, when considering issues related to lens selection.
05/31/2023
Vuity Gets Increased Dosing Nod
New, broader latitude for use should overcome some concerns over durability of effect.
03/31/2023
Presbyopia Drugs: A Drop in the Bucket?
With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?
03/15/2023
